Mr. Cruz (for himself and Mr. Welch) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation
To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023. S. 1280. 118th
Cong., 1st
sess., Introduced in Senate April 25, 2023. https://www.govinfo.gov/app/details/BILLS-118s1280is.
APA
Congress, Senate (2023, April 25). Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 (S. 1280 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118s1280is.
MLA
United States, Congress, Senate. Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118s1280is. 118th Congress, S. 1280, Introduced in Senate 25 Apr. 2023.
Bluebook
S.1280 - 118th Congress (2023-2024): Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023, S.1280, 118th Cong. (2023), https://www.govinfo.gov/app/details/BILLS-118s1280is.
